Mild Traumatic Brain Injury: Clinical Trials

16 trials for Mild Traumatic Brain Injury, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 5 recruiting, 2 not yet recruiting, 2 terminated. 16 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 216Completed 5, Recruiting 5, Not yet recruiting 2, Terminated 2, Enrolling by invitation 1, Withdrawn 1
Phase 12Completed 2
Phase 32Not yet recruiting 1, Recruiting 1

Follow Mild Traumatic Brain Injury: new trials by email Literature Review of Mild Traumatic Brain Injury trials Research Report on Mild Traumatic Brain Injury

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Memantine Targeting Neurovascular Dysfunction After Mild and Moderate Traumatic Brain Injury (MEND)
Memantine - Traumatic Brain Injury, Mild Traumatic Brain Injury
Phase 2Not yet recruitingNova Scotia Health Authority452027-06-012026-10-09
Repurposing Insulin With Intranasal Administration to Improve Function After Mild Traumatic Brain Injury
Insulin (Humulin), Placebo - Concussion (Diagnosis), Mild Traumatic Brain Injury
Phase 2RecruitingHealthPartners Institute962026-11-012026-11-13
Randomized Controlled Trial of Treatment to Optimize Heart Rate Variability for Persistent Post-Concussion Symptoms
HRV Coherence Ratio, NSI, Pittsburgh Sleep Quality Index (PSQI) - Autonomic Nervous System Disease, Concussive Injury
Phase 2 / Phase 3RecruitingVirginia Commonwealth University1482025-09-022026-09-22
Memantine as an Additive Therapy in Patients With Traumatic Brain Injury
Memantine, Mannitol - Mild Traumatic Brain Injury, Moderate Traumatic Brain Injury (TBI)
Phase 2 / Phase 3Not yet recruitingMansoura University802025-03-252025-04-06
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
Active cTBS, Inactive/Sham cTBS, Imaginal exposure - Post-Concussion Syndrome, Concussion, Brain
Phase 2RecruitingUniversity of California, Los Angeles752024-03-062026-02-24
Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History
High Definition Transcranial Direct Current Stimulation - Mild Cognitive Impairment, Amnestic Mild Cognitive Disorder
Phase 2RecruitingUniversity of Texas Southwestern Medical Center752023-04-202026-07-20
Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI
Erenumab 140 Mg/mL Subcutaneous Solution, Placebo - Posttraumatic Headache, Mild Traumatic Brain Injury
Phase 2RecruitingHenry M. Jackson Foundation for the Advancement of Military Medicine4042022-07-192024-02-22
Exercise as Concussion Therapy Trial- 2
Graded Exercise Therapy: ClearPlay(TM) - Mild Traumatic Brain Injury, Concussion, Mild
Phase 2WithdrawnANSwers Neuroscience, Inc.2020-10-012022-03-03
Efficacy and Tolerability of Erenumab in the Prophylactic Treatment of Persistent Post-Traumatic Headache
AMG 334 - Post-Traumatic Headache, Mild Traumatic Brain Injury
Phase 2CompletedDanish Headache Center1002019-04-052020-02-10
Pilot rTMS for AUD+mTBI
repetitive transcranial magnetic stimulation - Alcohol Use Disorder, Mild Traumatic Brain Injury
Phase 2TerminatedVA Office of Research and Development22019-03-212026-10-30
rTMS Target Identification for Functional Disability in AUD+mTBI
Magventure MagProX100 with MagOption stimulator and Magpro Cool Coil B65 A/P - Alcohol Use Disorder, Mild Traumatic Brain Injury
Phase 2Enrolling by invitationVA Office of Research and Development1002019-01-012026-04-08
OPTIMA-TBI Pilot Study
Omega-3 Polyunsaturated Fatty Acids (Fish Oil 1000 mg (contains 500 mg DHA & 100 mg EPA)) or placebo capsules., Placebo - Cap - Mild Traumatic Brain Injury
Phase 2TerminatedUniversity of Michigan442017-09-122023-05-23
rTMS Treatment of Persistent Headache and Post Concussion Symptoms Attributed to Mild Traumatic Injury to the Head
rTMS - Real Air Film Coil, rTMS - Sham Coil - Brain Injuries, Traumatic, Concussion, Brain
Phase 1 / Phase 2CompletedUniversity of Calgary202017-04-152019-04-22
Chronic Postconcussive Headache: A Placebo-Controlled Treatment Trial of Prazosin
prazosin hydrochloride, placebo - Posttraumatic Headache, Combat Disorders
Phase 1 / Phase 2CompletedVA Office of Research and Development892016-01-042026-03-30
Hyperbaric Oxygen Therapy (HBO2T) for Post-Concussive Symptoms (PSC) After Mild Traumatic Brain Injury (mTBI)
Hyperbaric Oxygen Therapy - Mild Traumatic Brain Injury, Post-Concussive Syndrome
Phase 2CompletedVirginia Commonwealth University602010-06-012013-08-27
An Intervention Program to Reduce to the Risk of Persistent Symptoms After Concussion
Treatment as usual, Cognitive-behavioural therapy - Mild Traumatic Brain Injury
Phase 2CompletedUniversity of British Columbia282009-06-012018-11-06

Narrower conditions

Brain Concussion (16)  ·  Post-Concussion Syndrome (5)  ·  Brain Injuries, Traumatic (4)  ·  Post-Traumatic Headache (4)  ·  Headache (3)  ·  Stress Disorders, Post-Traumatic (3)  ·  Alcoholism (2)  ·  Anxiety Disorders (1)  ·  Autonomic Nervous System Diseases (1)  ·  Cognitive Dysfunction (1)  ·  Combat Disorders (1)  ·  Craniocerebral Trauma (1)  ·  Depression (1)  ·  Disease (1)  ·  Dizziness (1)

Broader conditions

Brain Diseases (16)  ·  Brain Injuries (16)  ·  Central Nervous System Diseases (16)  ·  Head Injuries, Closed (16)  ·  Nervous System Diseases (16)  ·  Trauma, Nervous System (16)  ·  Wounds and Injuries (16)  ·  Wounds, Nonpenetrating (16)  ·  Craniocerebral Trauma (15)  ·  Brain Injuries, Traumatic (12)  ·  Mental Disorders (6)  ·  Headache Disorders, Secondary (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Stress Disorders, Traumatic (4)  ·  Trauma and Stressor Related Disorders (4)

Interventions

Memantine (2)  ·  Transcranial Magnetic Stimulation (2)  ·  erenumab (2)  ·  Cognitive Behavioral Therapy (1)  ·  Docosahexaenoic Acids (1)  ·  Fish Oils (1)  ·  Hyperbaric Oxygenation (1)  ·  Implosive Therapy (1)  ·  Insulin (1)  ·  Mannitol (1)  ·  Patient Health Questionnaire (1)  ·  Prazosin (1)  ·  Therapeutics (1)

Sponsors

VA Office of Research and Development (3)  ·  Virginia Commonwealth University (2)  ·  ANSwers Neuroscience, Inc. (1)  ·  Danish Headache Center (1)  ·  HealthPartners Institute (1)  ·  Henry M. Jackson Foundation for the Advancement of Military Medicine (1)  ·  Mansoura University (1)  ·  Nova Scotia Health Authority (1)  ·  University of British Columbia (1)  ·  University of Calgary (1)  ·  University of California, Los Angeles (1)  ·  University of Michigan (1)  ·  University of Texas Southwestern Medical Center (1)

Countries

United States (10)  ·  Canada (3)  ·  Australia (1)  ·  Denmark (1)  ·  Egypt (1)

Top investigators

Amy A Herrold, PhD BA (2)  ·  Alice Rose (1)  ·  Allen Thornton (1)  ·  Alon Friedman, MD PhD (1)  ·  Bhavani Kashyap, MBBS, PhD (1)  ·  Brad Hallam (1)  ·  Brett Hart, MD (1)  ·  Chantel Debert, MD MSc FRCPC (1)  ·  Christina Master, MD (1)  ·  Cynthia L Mayer, DO (1)  ·  David B Clarke, MDCM PhD (1)  ·  David L Brody, MD, PhD (1)  ·  David X Cifu, MD (1)  ·  Ellen Parker, MD PhD (1)  ·  Frederick Korley, M.D., Ph.D. (1)

Results publications

PMID 31530227, PMID 32493206, PMID 33165153, PMID 40550124

NIH funding

1IK2RX001136-01A2 (1), 2018 (1), I01RX002916 (1), IK2RX000949 (1)